Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting

Journal of Pain Research

Volumn 4, Issue , 2011, Pages 373-384

  Brown, James ^a   Setnik, Beatrice ^b   Lee, Keung ^c   Cleveland, Jody M ^b   Roland, Carl L ^b   Wase, Linda ^d   Webster, Lynn ^e  

^a Jena Medical   (United States)

^b PFIZER INC   (United States)

^c Randolph Medical Associates   (United States)

^d Archimedes Pharma US Inc   (United States)

^e Lifetree Clinical Research   (United States)

Author keywords

Analgesics; Opioids; Pain assessment; Primary care; Substance abuse; Universal precautions

Indexed keywords

EID: 84870685350     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S23024     Document Type: Article

References (28)

1. Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA. 2007;297:249-251.
2. Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication No SMA 09-4434). Rockville, MD; 2009. Available at: http://www.oas.samhsa.gov/nsduh/2k8nsduh/2k8results.cfm. Accessed October 2, 2009.
3. Gagnon AM, Kahan M, Srivastava A. Opioid use and abuse: is there a problem? Clin J Pain. 2007;23:661-662.
4. Chou R, Fanciullo GJ, Fine PG, et al. Opioid treatment guidelines. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113-130.
5. Wasan AD, Wootton J, Jamison RN. Dealing with difficult patients in your pain practice. Reg Anesth Pain Med. 2005;30:184-192.
6. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6:107-112.
7. Passik SD, Kirsh KL. Forget the recipes: let's talk data. Pain Med. 2009;9:261-265.
8. Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by US primary care physicians from 1992 to 2001. J Pain. 2006;7:225-235.
9. Katz NP, Adams EH, Benneyan JC, et al. Foundations of opioid risk management. Clin J Pain. 2007;23:103-118.
10. Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6:46.
11. Reid MC, Engles-Horton LL, Weber MB, et al. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17:173-179.
12. Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med. 2007;8:573-584.
13. Olsen Y, Daumit GL. Opioid prescribing for chronic nonmalignant pain in primary care: challenges and solutions. Adv Psychosom Med. 2004;25:138-150.
14. King Pharmaceuticals Inc. Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza (ACCESS 2008). In: ClinicalTrials. gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[April 26, 2010]. Available from: http://clinicaltrials.gov/ct2/show/NCT00640042 NLM Identifier: NCT00640042. Accessed December 8, 2010.
15. Avinza [package insert]. Bristol, TN: King Pharmaceuticals Inc; April 2008.
16. Caldwell JR, Rapoport RJ, Davis JC, et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage. 2002;23:278-291.
17. Portenoy RK, Sciberras A, Eliot L, et al. Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain. J Pain Symptom Manage. 2002;23:292-300.
18. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129-138.
19. Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008;9:360-372.
20. Brown J, Setnik B, Lee K, et al. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting. J Opioid Manag. In press.
21. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-158.
22. Farrar JT, Pritchett YL, Robinson M, Prakash A, Chappell A. The clinical importance of changes in the 0-10 numeric rating scale for worst, least, and average pain intensity: analysis of data from clinical trials of duloxetine in pain disorders. J Pain. 2010;11:109-118.
23. Rauck R, Bookbinder S, Bunker T, et al. The ACTION study: a randomized, open label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (Avinza) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. J Opioid Manage. 2006;2:155-166.
24. Adams EH, Chwiecko P, Ace-Wagoner Y, et al. A study of Avinza (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions-the ACCPT Study. Pain Pract. 2006;6:254-264.
25. Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med. 2000;160:853-860.
26. Nicholson B, Ross E, Sasaki J, Weil A. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain. Curr Med Res Opin. 2006;22:1503-1514.
27. Webster LR, Butera PG, Moran LV, et al. Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain. J Pain. 2006;7:937-946.
28. Katz N, Rauck R, Ahdieh H, et al. A 12-week, randomized, placebocontrolled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Curr Med Res Opin. 2007;23:117-128.